Previous studies regarding the therapeutic effectiveness of Lactobacillus species on diabetes and its complications were focus on increasing insulin sensitivity [68] or delaying the onset of glucose intolerance, hyperglycemia, hyperinsulinemia, dyslipidemia, and oxidative stress [17,19,69]. This evidence concerns the gene INS and hyperinsulinism.